Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
Price Target
Average
148.11%
Revenue Forecast
Estimate
47.11%
EBIT
Estimate
--45.37%
Net Income
Estimate
33.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ultragenyx Pharmaceutical Inc.
Wall Street analysts predict an average 1-year price target for RARE of $105 , with forecasts ranging from
a
low of
$67 to a high of $135 .
RARE Lowest Price Target
Wall Street Target
67 USD
58.15%
RARE Average Price Target
Wall Street Target
105 USD
148.11%
RARE Highest Price Target
Wall Street Target
135 USD
218.66%
REVENUE FORECAST
Revenue Forecast Chart RARE
EBIT FORECAST
EBIT Forecast Chart RARE
NET INCOME FORECAST
Net Income Chart RARE